A detailed history of Ubs Group Ag transactions in Myomo, Inc. stock. As of the latest transaction made, Ubs Group Ag holds 40,478 shares of MYO stock, worth $245,296. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40,478
Previous 2,330 1637.25%
Holding current value
$245,296
Previous $7,000 2214.29%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$2.81 - $5.63 $107,195 - $214,773
38,148 Added 1637.25%
40,478 $162,000
Q2 2024

Aug 13, 2024

SELL
$2.7 - $4.06 $15,279 - $22,975
-5,659 Reduced 70.83%
2,330 $7,000
Q1 2024

May 13, 2024

BUY
$2.75 - $4.97 $21,969 - $39,705
7,989 New
7,989 $26,000
Q3 2023

Nov 09, 2023

BUY
$0.55 - $1.31 $275,045 - $655,107
500,082 New
500,082 $555,000
Q1 2023

May 12, 2023

BUY
$0.4 - $0.77 $1,453 - $2,797
3,633 New
3,633 $2,000
Q3 2022

Nov 10, 2022

BUY
$1.62 - $2.1 $534 - $693
330 New
330 $1,000
Q2 2022

Aug 10, 2022

SELL
$1.64 - $4.05 $1,441 - $3,559
-879 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$3.81 - $8.51 $371,631 - $830,073
-97,541 Reduced 99.11%
879 $3,000
Q4 2021

Feb 14, 2022

SELL
$6.84 - $14.0 $471 - $966
-69 Reduced 0.07%
98,420 $675,000
Q3 2021

Nov 15, 2021

BUY
$7.53 - $12.69 $740,816 - $1.25 Million
98,382 Added 91945.79%
98,489 $1.17 Million
Q2 2021

Aug 13, 2021

SELL
$8.92 - $13.22 $4,754 - $7,046
-533 Reduced 83.28%
107 $1,000
Q1 2021

May 12, 2021

BUY
$6.8 - $18.14 $3,855 - $10,285
567 Added 776.71%
640 $8,000
Q4 2020

Feb 11, 2021

SELL
$4.34 - $7.86 $2,048 - $3,709
-472 Reduced 86.61%
73 $0
Q3 2020

Nov 12, 2020

SELL
$3.52 - $5.35 $11,066 - $16,820
-3,144 Reduced 85.23%
545 $2,000
Q2 2020

Jul 31, 2020

BUY
$3.3 - $4.7 $617 - $878
187 Added 5.34%
3,689 $14,000
Q1 2020

May 01, 2020

BUY
$3.0 - $24.5 $10,506 - $85,799
3,502 New
3,502 $13,000

Others Institutions Holding MYO

About MYOMO, INC.


  • Ticker MYO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 7,000,170
  • Market Cap $42.4M
  • Description
  • Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activ...
More about MYO
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.